EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma

Mohammed S Abdulrahman, Omnia Aboelmagd, Ying Zhang, Samy Zaky, Dina Johar

World Journal of Biological Chemistry · 05.06.2026 · 17 (2)

DOI: 10.4331/wjbc.v17.i2.120297 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift World Journal of Biological Chemistry, online erschienen am 05.06.2026. Verfasst von Mohammed S Abdulrahman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) reactivation after targeted therapy or immunomodulating therapy leads to active or fulminant hepatitis, low response to prophylactic vaccination, premature discharge from therapy and death. The hypothesis that seroreactive viral infection is caused by mutation/s in the precore/core is invaluable to elucidating the mechanisms of HBV reactivation. Precore/core mutations may correlate with, or predict susceptibility to seroreactivation in HBV-related hepatocellular carcinoma (HCC) patients receiving targeted therapy. This review’s objective is to re-analyze the relationship between the precore/core mutations of HBV-DNA and HBV reactivation in HCC patients receiving targeted therapy. Further, to re-analyze clinically significant precore/core mutations affecting pregenomic RNA initiation and synthesis, and their regulation of viral and cellular gene expressions. This review shed light on the mechanism of HBV reactivation. We analyze the effects of antivirals lamivudine, entecavir, tenofovir alafenamide, tenofovir disoproxil fumarate and immune-based strategies on reactivation after treatment for HBV-related HCC. We proposed future directions for studying mutations in the precore/core region that are likely to cause relapse. This review recommends comparing the genome/proteome of blood from overt and relapsed HCC-related chronic HBV patients. This helps identifying persistent genetic/epigenetic profiles of HBV resistant variants, thus accurately selecting the appropriate antiviral therapy and eliminating the risk of viral reactivation.

Schlagwörter

Stichwörter der Autor:innen

EntecavirHepatitis B virusHepatocellular carcinomaLamivudinePrecore/core mutationsReactivationTenofovir alafenamideTenofovir disoproxil fumarate

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Menoufia National University, Menoufia 32658, Egypt.
  • Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo 11562, Egypt.
  • School of Basic Medical Sciences, Binzhou Medical University, Yantai 264003, Shandong Province, China.
  • Department of Hepatogastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Cairo 11651, Egypt.
  • Department of Biochemistry and Nutrition, Faculty of Women for Arts, Sciences and Education, Ain Shams University, Cairo 11757, Egypt. dinajohar@gu.edu.eg.

Zitieren

APA

Abdulrahman, M. S., Aboelmagd, O., Zhang, Y., Zaky, S., & Johar, D. (2026). Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma. World Journal of Biological Chemistry, 17(2). https://doi.org/10.4331/wjbc.v17.i2.120297

Vancouver

Abdulrahman MS, Aboelmagd O, Zhang Y, Zaky S, Johar D. Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma. World Journal of Biological Chemistry. 2026;17(2). doi:10.4331/wjbc.v17.i2.120297

BibTeX
@article{Abdulrahman2026,
  author = {Abdulrahman, Mohammed S and Aboelmagd, Omnia and Zhang, Ying and Zaky, Samy and Johar, Dina},
  title = {Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma},
  journal = {World Journal of Biological Chemistry},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.4331/wjbc.v17.i2.120297}
}
Kostenlos starten →